Investigating STEAP2 as a potential therapeutic target for the treatment of aggressive prostate cancer

Leia A. Jones, Gillian E. Conway, Aimy Nguyen Chi, Stephanie Burnell, Gareth J. Jenkins, R. Steven Conlan, Shareen H. Doak

Research output: Contribution to journalArticlepeer-review


The expression of six transmembrane epithelial antigen of the prostate (STEAP2) is increased in prostate cancer when compared to normal tissue, suggesting a role for STEAP2 in disease progression. This study aimed to determine whether targeting STEAP2 with an anti-STEAP2 polyclonal antibody (pAb) or CRISPR/Cas9 knockout influenced aggressive prostate cancer traits. Gene expression analysis of the STEAP gene family was performed in a panel of prostate cancer cell lines; C4-2B, DU145, LNCaP and PC3. The highest increases in STEAP2 gene expression were observed in C4-2B and LNCaP cells (p<0.001 and p<0.0001 respectively) when compared to normal prostate epithelial PNT2 cells. These cell lines were treated with an anti-STEAP2 pAb and their viability assessed. CRISPR/Cas9 technology was used to knockout STEAP2 from C4-2B and LNCaP cells and viability, proliferation, migration and invasion assessed. When exposed to an anti-STEAP2 pAb, cell viability significantly decreased (p<0.05). When STEAP2 was knocked out, cell viability and proliferation was significantly decreased when compared to wild-type cells (p<0.001). The migratory and invasive potential of knockout cells were also decreased. These data suggest that STEAP2 has a functional role in driving aggressive prostate cancer traits and could provide a novel therapeutic target for the treatment of prostate cancer.

Original languageEnglish (US)
Pages (from-to)179-187
Number of pages9
JournalCellular and Molecular Biology
Issue number4
StatePublished - Apr 30 2023


  • antibody
  • biomarker
  • CRISPR/Cas9
  • invasion
  • metastasis
  • proliferation
  • Prostate cancer
  • STEAP2
  • Humans
  • Male
  • Prostate/metabolism
  • Gene Expression Profiling
  • Cell Line, Tumor
  • Prostatic Neoplasms/metabolism

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry
  • Cell Biology


Dive into the research topics of 'Investigating STEAP2 as a potential therapeutic target for the treatment of aggressive prostate cancer'. Together they form a unique fingerprint.

Cite this